Rodney Barnett White
Examiner (ID: 4089, Phone: (571)272-6863 , Office: P/3636 )
Most Active Art Unit | 3636 |
Art Unit(s) | 3636, 3507, 3624 |
Total Applications | 3742 |
Issued Applications | 3058 |
Pending Applications | 192 |
Abandoned Applications | 490 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16792967
[patent_doc_number] => 20210122784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/092970
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092970 | PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF | Nov 8, 2020 | Abandoned |
Array
(
[id] => 18478281
[patent_doc_number] => 11692011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Hepatitis B virus-derived polypeptide and anti-viral use thereof
[patent_app_type] => utility
[patent_app_number] => 17/090485
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 40
[patent_no_of_words] => 9537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090485 | Hepatitis B virus-derived polypeptide and anti-viral use thereof | Nov 4, 2020 | Issued |
Array
(
[id] => 17435910
[patent_doc_number] => 11261222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Transdermal peptide with nuclear localization ability and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/090125
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3799
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090125 | Transdermal peptide with nuclear localization ability and use thereof | Nov 4, 2020 | Issued |
Array
(
[id] => 17007076
[patent_doc_number] => 20210238237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHOD OF MANAGING JOINT PAIN
[patent_app_type] => utility
[patent_app_number] => 17/085023
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085023 | Method of managing joint pain | Oct 29, 2020 | Issued |
Array
(
[id] => 18559802
[patent_doc_number] => 11725036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Modified lipidated relaxin B chain peptides and their therapeutic use
[patent_app_type] => utility
[patent_app_number] => 17/086183
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16838
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086183 | Modified lipidated relaxin B chain peptides and their therapeutic use | Oct 29, 2020 | Issued |
Array
(
[id] => 16715390
[patent_doc_number] => 20210082537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => SELECTIVE PEPTIDE ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/083099
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083099 | Selective peptide antagonists | Oct 27, 2020 | Issued |
Array
(
[id] => 16990270
[patent_doc_number] => 20210228690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Anti-Inflammatory Peptides and Composition Comprising the Same
[patent_app_type] => utility
[patent_app_number] => 17/080653
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080653 | Anti-inflammatory peptides and composition comprising the same | Oct 25, 2020 | Issued |
Array
(
[id] => 16620051
[patent_doc_number] => 20210038704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => H3.3 CTL PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/077806
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077806 | H3.3 CTL peptides and uses thereof | Oct 21, 2020 | Issued |
Array
(
[id] => 17741460
[patent_doc_number] => 11389505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method of managing joint pain
[patent_app_type] => utility
[patent_app_number] => 17/067278
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11337
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067278 | Method of managing joint pain | Oct 8, 2020 | Issued |
Array
(
[id] => 18747053
[patent_doc_number] => 11806342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Diiodohydroxyquinoline for the treatment of clostridium difficile infection
[patent_app_type] => utility
[patent_app_number] => 17/063750
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9007
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063750 | Diiodohydroxyquinoline for the treatment of clostridium difficile infection | Oct 5, 2020 | Issued |
Array
(
[id] => 16569148
[patent_doc_number] => 20210008154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
[patent_app_type] => utility
[patent_app_number] => 17/026543
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026543 | Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells | Sep 20, 2020 | Issued |
Array
(
[id] => 18518512
[patent_doc_number] => 11708392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Peptide conjugates
[patent_app_type] => utility
[patent_app_number] => 17/012724
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 44
[patent_no_of_words] => 35551
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012724 | Peptide conjugates | Sep 3, 2020 | Issued |
Array
(
[id] => 16523782
[patent_doc_number] => 20200397862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => Methods of Treating Fungal Infections
[patent_app_type] => utility
[patent_app_number] => 17/011165
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011165 | Methods of treating fungal infections | Sep 2, 2020 | Issued |
Array
(
[id] => 18084370
[patent_doc_number] => 11534477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Use of peptide compounds in treating acute pancreatitis
[patent_app_type] => utility
[patent_app_number] => 17/011052
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6365
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011052 | Use of peptide compounds in treating acute pancreatitis | Sep 2, 2020 | Issued |
Array
(
[id] => 16655320
[patent_doc_number] => 20210051956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => ELASNIN, A BACTERIOSTATIC AGENT THAT HAS POTENT ANTIBIOFILM ACTIVITIES AGAINST BOTH MONO- AND MULTI-SPECIES BIOFILM
[patent_app_type] => utility
[patent_app_number] => 16/999437
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999437 | ELASNIN, A BACTERIOSTATIC AGENT THAT HAS POTENT ANTIBIOFILM ACTIVITIES AGAINST BOTH MONO- AND MULTI-SPECIES BIOFILM | Aug 20, 2020 | Pending |
Array
(
[id] => 16564260
[patent_doc_number] => 10889619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Methods for treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/934583
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12045
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16934583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/934583 | Methods for treating cancer | Jul 20, 2020 | Issued |
Array
(
[id] => 17657055
[patent_doc_number] => 20220177520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => PEPTIDES INHIBITING ANDROGEN RECEPTOR ACTIVITY, AND COSMETICS COMPOSITION USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/605723
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605723 | PEPTIDES INHIBITING ANDROGEN RECEPTOR ACTIVITY, AND COSMETICS COMPOSITION USING SAME | Jul 19, 2020 | Abandoned |
Array
(
[id] => 16570633
[patent_doc_number] => 20210009639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS
[patent_app_type] => utility
[patent_app_number] => 16/924745
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16924745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/924745 | INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS | Jul 8, 2020 | Abandoned |
Array
(
[id] => 17822679
[patent_doc_number] => 11427617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Compositions and methods for treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 16/913699
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6109
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913699 | Compositions and methods for treatment of fungal infections | Jun 25, 2020 | Issued |
Array
(
[id] => 17635183
[patent_doc_number] => 11345899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Variant forms of urate oxidase and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/911074
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 13806
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911074 | Variant forms of urate oxidase and use thereof | Jun 23, 2020 | Issued |